191 related articles for article (PubMed ID: 17308920)
21. Evaluation of a New
Farahani AM; Maleki F; Sadeghzadeh N; Abediankenari S; Abedi SM; Erfani M
Anticancer Agents Med Chem; 2020; 20(14):1695-1703. PubMed ID: 32560611
[TBL] [Abstract][Full Text] [Related]
22. Detection of somatostatin receptor-positive tumours using the new 99mTc-tricine-HYNIC-D-Phe1-Tyr3-octreotide: first results in patients and comparison with 111In-DTPA-D-Phe1-octreotide.
Bangard M; Béhé M; Guhlke S; Otte R; Bender H; Maecke HR; Biersack HJ
Eur J Nucl Med; 2000 Jun; 27(6):628-37. PubMed ID: 10901448
[TBL] [Abstract][Full Text] [Related]
23. Cholecystokinin-B/Gastrin receptor-targeting peptides for staging and therapy of medullary thyroid cancer and other cholecystokinin-B receptor-expressing malignancies.
Behr TM; Béhé MP
Semin Nucl Med; 2002 Apr; 32(2):97-109. PubMed ID: 11965605
[TBL] [Abstract][Full Text] [Related]
24. Preliminary application of micro-SPECT/CT imaging by
Zhang Y; Meng L; Li B; Tan H; Lin QY; Cheng D; Shi H
Chem Biol Drug Des; 2019 Apr; 93(4):447-453. PubMed ID: 30381892
[TBL] [Abstract][Full Text] [Related]
25. Radiolabeled peptides for targeting cholecystokinin-B/gastrin receptor-expressing tumors.
Behr TM; Jenner N; Béhé M; Angerstein C; Gratz S; Raue F; Becker W
J Nucl Med; 1999 Jun; 40(6):1029-44. PubMed ID: 10452322
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of tricine and EDDA as Co-ligands for 99mTc-labeled HYNIC-MSH analogs for melanoma imaging.
Garcia MF; Zhang X; Gallazzi F; Fernandez M; Moreno M; Gambini JP; Porcal W; Cabral P; Quinn TP
Anticancer Agents Med Chem; 2015; 15(1):122-30. PubMed ID: 25175799
[TBL] [Abstract][Full Text] [Related]
27. [The role of scintigraphy with the use of 99mTc-HYNIC-TOC in the diagnosis of medullary thyroid carcinoma].
Czepczyński R; Kosowicz J; Ziemnicka K; Mikołajczak R; Gryczyńska M; Sowiński J
Endokrynol Pol; 2006; 57(4):431-5. PubMed ID: 17006849
[TBL] [Abstract][Full Text] [Related]
28. Comparison of three radiolabelled peptide analogues for CCK-2 receptor scintigraphy in medullary thyroid carcinoma.
Fröberg AC; de Jong M; Nock BA; Breeman WA; Erion JL; Maina T; Verdijsseldonck M; de Herder WW; van der Lugt A; Kooij PP; Krenning EP
Eur J Nucl Med Mol Imaging; 2009 Aug; 36(8):1265-72. PubMed ID: 19266197
[TBL] [Abstract][Full Text] [Related]
29. [
Kaihani S; Sadeghzadeh N; Abediankenari S; Abedi SM
Ann Nucl Med; 2022 Nov; 36(11):976-985. PubMed ID: 36097232
[TBL] [Abstract][Full Text] [Related]
30. Optimised labeling, preclinical and initial clinical aspects of CCK-2 receptor-targeting with 3 radiolabeled peptides.
Breeman WA; Fröberg AC; de Blois E; van Gameren A; Melis M; de Jong M; Maina T; Nock BA; Erion JL; Mäcke HR; Krenning EP
Nucl Med Biol; 2008 Nov; 35(8):839-49. PubMed ID: 19026945
[TBL] [Abstract][Full Text] [Related]
31. In vitro evaluation of (99m)Tc-EDDA/tricine-HYNIC-Q-Litorin in gastrin-releasing peptide receptor positive tumor cell lines.
Yurt Lambrecht F; Durkan K; Ozgür A; Gündüz C; Avcı CB; Susluer SY
J Drug Target; 2013 May; 21(4):383-8. PubMed ID: 23301856
[TBL] [Abstract][Full Text] [Related]
32. Synthesis, characterization, conformational analysis of a cyclic conjugated octreotate peptide and biological evaluation of (99m)Tc-HYNIC-His(3)-Octreotate as novel tracer for the imaging of somatostatin receptor-positive tumors.
Behera A; Banerjee I; De K; Munda RN; Chattopadhayay S; Samanta A; Sarkar B; Ganguly S; Misra M
Amino Acids; 2013 Mar; 44(3):933-46. PubMed ID: 23090293
[TBL] [Abstract][Full Text] [Related]
33. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
34. Clinical translation of a PSMA inhibitor for
Ferro-Flores G; Luna-Gutiérrez M; Ocampo-García B; Santos-Cuevas C; Azorín-Vega E; Jiménez-Mancilla N; Orocio-Rodríguez E; Davanzo J; García-Pérez FO
Nucl Med Biol; 2017 May; 48():36-44. PubMed ID: 28193503
[TBL] [Abstract][Full Text] [Related]
35. Cyclic minigastrin analogues for gastrin receptor scintigraphy with technetium-99m: preclinical evaluation.
von Guggenberg E; Sallegger W; Helbok A; Ocak M; King R; Mather SJ; Decristoforo C
J Med Chem; 2009 Aug; 52(15):4786-93. PubMed ID: 19591486
[TBL] [Abstract][Full Text] [Related]
36. Preparation and evaluation of 99mTc-EDDA/HYNIC-[Lys 3]-bombesin for imaging gastrin-releasing peptide receptor-positive tumours.
Ferro-Flores G; Arteaga de Murphy C; Rodriguez-Cortés J; Pedraza-López M; Ramírez-Iglesias MT
Nucl Med Commun; 2006 Apr; 27(4):371-6. PubMed ID: 16531924
[TBL] [Abstract][Full Text] [Related]
37. Lys3-bombesin conjugated to 99mTc-labelled gold nanoparticles for in vivo gastrin releasing peptide-receptor imaging.
Mendoza-Sánchez AN; Ferro-Flores G; Ocampo-García BE; Morales-Avila E; de M Ramírez F; De León-Rodríguez LM; Santos-Cuevas CL; Medina LA; Rojas-Calderón EL; Camacho-López MA
J Biomed Nanotechnol; 2010 Aug; 6(4):375-84. PubMed ID: 21323111
[TBL] [Abstract][Full Text] [Related]
38. Analysis of accumulation of 99mTc-octreotide and 99mTc-EDDA/HYNIC-Tyr3-octreotide in the rat kidneys.
Kopecky M; Semecky V; Trejtnar F; Laznicek M; Laznickova A; Nachtigal P; Decristoforo C; Mather SJ; Mäcke HR
Nucl Med Biol; 2004 Feb; 31(2):231-9. PubMed ID: 15013489
[TBL] [Abstract][Full Text] [Related]
39. Macrocyclic chelator-coupled gastrin-based radiopharmaceuticals for targeting of gastrin receptor-expressing tumours.
Good S; Walter MA; Waser B; Wang X; Müller-Brand J; Béhé MP; Reubi JC; Maecke HR
Eur J Nucl Med Mol Imaging; 2008 Oct; 35(10):1868-77. PubMed ID: 18509636
[TBL] [Abstract][Full Text] [Related]
40. Human Fibronectin Extra-Domain B (EDB)-Specific Aptide (APTEDB) Radiolabelling with Technetium-99m as a Potent Targeted Tumour-Imaging Agent.
Mohammadgholi M; Sadeghzadeh N; Erfani M; Abediankenari S; Abedi SM; Emrarian I; Jafari N; Behzadi R
Anticancer Agents Med Chem; 2018; 18(2):277-285. PubMed ID: 28925879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
